Inflammation & Allergy - Drug Targets (Discontinued)

(Formerly Current Drug Targets - Inflammation & Allergy)

ISSN (Print): 1871-5281
ISSN (Online): 2212-4055

Volume 14 , Issue 0 , 2015

Back Journal Home
Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Inflammation & Allergy - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in inflammation and allergy e.g. disease specific proteins, receptors, enzymes, genes. The journal publishes expert in-depth reviews, original research articles, drug clinical trial studies and guest edited thematic issues covering a range of current topics on drug targets involved in inflammation and allergy. As the discovery, identification, characterization and validation of novel human drug targets for anti-inflammation and allergy drug discovery continue to grow, this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted/Indexed in


MEDLINE/PubMed/Index Medicus, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, EMBASE/Excerpta Medica, Chemical Abstracts, ProQuest, PubsHub, Genamics JournalSeek, MediaFinder®-Standard Periodical Directory, J-Gate, CNKI Scholar, Suweco CZ, EBSCO, QOAM, and Dimensions.

Announcements
Endorsement(s)

"Inflammation & Allergy - Drug Targets is an important review journal, which supplies up-to-date topics in this field for all pharmaceutical scientists."

Kenji Izuhara
Saga Medical School, Japan

Authors' Comments

I have had a good experience with Bentham Science Publishers, as it has an easy submission and editorial process supported with great communication by the managers.

Dr. Alberto F. Rubio-Guerra
(The Clinical Research Unit, Hospital General de Ticoman. México DF, And Mexican Group for Basic and Clinical Research in Internal Medicine, Mexico)

Has contributed: Correlation Between Circulating Adhesion Molecules and Resistin Levels in Hypertensive Type-2 Diabetic Patients

© 2022 Bentham Science Publishers | Privacy Policy